Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2191-219X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients ; volume:9 ; number:1 ; day:7 ; month:2 ; year:2019 ; pages:1-12 ; date:12.2019
EJNMMI Research ; 9, Heft 1 (7.2.2019), 1-12, 12.2019
- Urheber
-
Kolinger, Guilherme D.
Vállez García, David
Kramer, Gerbrand M.
Frings, Virginie
Smit, Egbert F.
de Langen, Adrianus J.
Dierckx, Rudi A. J. O.
Hoekstra, Otto S.
Boellaard, Ronald
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13550-019-0481-1
- URN
-
urn:nbn:de:101:1-2019031300242078763487
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kolinger, Guilherme D.
- Vállez García, David
- Kramer, Gerbrand M.
- Frings, Virginie
- Smit, Egbert F.
- de Langen, Adrianus J.
- Dierckx, Rudi A. J. O.
- Hoekstra, Otto S.
- Boellaard, Ronald
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Metabolically active tumour volume segmentation from dynamic [18F]FLT PET studies in non-small cell lung cancer
Mitigating SUV uncertainties using total body PET imaging
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)
Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET
Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner
Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation
Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements
Interlaboratory Surveys of the Determination of Tumour Markers Scatter and Repeatability of the Results
Off-line motion correction methods for multi-frame PET data
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Metabolically active tumour volume segmentation from dynamic [18F]FLT PET studies in non-small cell lung cancer
Mitigating SUV uncertainties using total body PET imaging
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)
Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET
Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner
Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation
Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements
Interlaboratory Surveys of the Determination of Tumour Markers Scatter and Repeatability of the Results
Off-line motion correction methods for multi-frame PET data
Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
Metabolically active tumour volume segmentation from dynamic [18F]FLT PET studies in non-small cell lung cancer
Mitigating SUV uncertainties using total body PET imaging
Total 18F-dopa PET tumour uptake reflects metabolic endocrine tumour activity in patients with a carcinoid tumour
Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
Harmonization of nomenclature for molecular imaging metrics of tumour burden: molecular tumour volume (MTV), total lesion activity (TLA) and total lesion fraction (TLF)
Repeatability of two semi-automatic artificial intelligence approaches for tumor segmentation in PET
Accuracy of 3D acquisition mode for myocardial FDG PET studies using a BGO-based scanner
Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [18F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation
Tumour necrosis as assessed with 18F-FDG PET is a potential prognostic marker in diffuse large B cell lymphoma independent of MYC rearrangements
Interlaboratory Surveys of the Determination of Tumour Markers Scatter and Repeatability of the Results